Maryline Beyler

USPTO Granted Patents = 7 (Patent Applications = 1)

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

7 out of 38

Université De Bretagne Occidentale

patents

7 out of 5,089

Centre National De La Recherche Scientifique

Ecole Normale Superieure De Lyon

patents

5. 1 out of 1

Université Claude Bernard Lyon 1 (ucbl1)

patent

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12269837 - Bifunctional do2pa derivatives, chelates with metallic cations and use thereof (2025-04-08),

2. 12103927 - Pyclen-based macrocyclic ligands, chelates thereof and uses thereof (2024-10-01),

3. 11266754 - Bifunctional do2pa derivatives, chelates with metallic cations and use thereof (2022-03-08),

4. 11155553 - Reinforced macrocyclic ligands, complexes thereof, and uses of same (2021-10-26),

5. 10981912 - Macrocyclic ligands with picolinate group(s), complexes thereof and also medical uses thereof (2021-04-20),

6. 10711001 - Macrocylic ligands with picolinate group(s), complexes thereof and also medical uses thereof (2020-07-14),

7. 9884881 - Chelates of lead (II) and bismuth (III) based on trans-di-N-picolinate tetraazacycloalkanes (2018-02-06),

Title: Maryline Beyler: Innovator in Chelation Chemistry

Introduction

Maryline Beyler is a prominent inventor based in Brest, France, known for her significant contributions to the field of chelation chemistry. With a total of seven patents to her name, she has made remarkable advancements in the development of bifunctional ligands and their applications in nuclear medicine and biological imaging.

Latest Patents

Among her latest patents is the invention of bifunctional do2pa derivatives, which are chelates formed through the complexation of these ligands with metallic cations, particularly Pb(II) and Bi(III). This innovation has potential applications in nuclear medicine and the detection or purification of effluents. Another notable patent involves pyclen-based macrocyclic ligands, which are designed for use in biological imaging and photoluminescence imaging. These ligands are characterized by their unique chromophore groups and can be manufactured through specific processes that enhance their functionality.

Career Highlights

Maryline has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Université de Bretagne Occidentale. Her work at these organizations has allowed her to explore and develop innovative solutions in her field, contributing to both academic research and practical applications.

Collaborations

Throughout her career, Maryline has collaborated with notable colleagues, including Raphaël Tripier and Mariane Le Fur. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in chelation chemistry.

Conclusion

Maryline Beyler's contributions to the field of chelation chemistry through her patents and collaborations highlight her role as a leading innovator. Her work continues to influence advancements in nuclear medicine and biological imaging, showcasing the importance of her research in practical applications.

This text is generated by artificial intelligence and may not be accurate.